Melissa A. Lasaro - Concepedia

Author

Melissa A. Lasaro

Alexion Pharmaceuticals (United States)

Also Known As

Melissa A Lasaro, Melissa A. Lasaro, Melissa A. S. Lasaro, Melissa Ang SimÃµes Lasaro, Melissa Lasaro

Publications

916

Citations

H-Index

Concepts

All Affiliations

Alexion Pharmaceuticals (United States)University of Pennsylvania Alexion Pharma (Switzerland)Universidade de São Paulo

About

Melissa A. Lasaro is an author at Alexion Pharmaceuticals (United States) specializing in medicine, immunology, and microbiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	480
2	Immunology	5	5	452
3	Health Sciences	2	2	267
4	Cell Biology	2	2	75
5	Allergy	1	1	239

Melissa A. Lasaro

Publications

751

Citations

H-Index

Page 1

	Year	Citations
Design and preclinical characterization of ALXN1210: A novel anti-C5 antibody with extended duration of action Douglas Sheridan, Zhao-Xue Yu, Yuchun Zhang, PLoS ONE ImmunohematologyImmunologyImmune RegulationExtended DurationImmune System	2018	239
Escherichia coli Isolate for Studying Colonization of the Mouse Intestine and Its Application to Two-Component Signaling Knockouts Melissa A. Lasaro, Zhi Liu, Rima A. Bishar, Journal of Bacteriology	2014	78
Effects of Psa and F1 on the Adhesive and Invasive Interactions of<i>Yersinia pestis</i>with Human Respiratory Tract Epithelial Cells Fengzhi Liu, Huaiqing Chen, Estela M. Galván, Infection and Immunity Microbial ToxinPh 6Medical MicrobiologyMicrobial PathogensMedicine	2006	75
Capsular Antigen Fraction 1 and Pla Modulate the Susceptibility of <i>Yersinia pestis</i> to Pulmonary Antimicrobial Peptides Such as Cathelicidin Estela M. Galván, Melissa A. Lasaro, Dieter M. Schifferli Infection and Immunity Acute Lung InjuryInflammatory Lung DiseaseMicrobial PathogensLung InflammationInnate Immune System	2008	63
Role of Complement Activation in Obliterative Bronchiolitis Post–Lung Transplantation Hidemi Suzuki, Mark E. Lasbury, Lin Fan, The Journal of Immunology	2013	56
Quantitative Systems Pharmacology Model of hUGT1A1‐modRNA Encoding for the UGT1A1 Enzyme to Treat Crigler‐Najjar Syndrome Type 1 Joshua F. Apgar, Tang Jian-ping, Pratap Singh, CPT Pharmacometrics & Systems Pharmacology	2018	44
Adhesin-dependent binding and uptake of Salmonella enterica serovar Typhimurium by dendritic cells Aizhen Guo, Melissa A. Lasaro, Jean‐Claude Sirard, Microbiology ImmunologyAdhesin-dependent BindingBone-marrow-derived DcsBacterial PathogenesisHost Response	2007	43
Efficacy of Targeted Complement Inhibition in Experimental C3 Glomerulopathy Marieta M. Ruseva, Tao Peng, Melissa A. Lasaro, Journal of the American Society of Nephrology Renal PathologyImmunologyRenal InflammationPathologyImmune Dysregulation	2015	32
First in Human Single-Ascending Dose Study: Safety, Biomarker, Pharmacokinetics and Exposure-Response Relationships of ALXN1210, a Humanized Monoclonal Antibody to C5, with Marked Half-Life Extension and Potential for Significantly Longer Dosing Intervals Leonardo Sahelijo, Arshad Mujeebuddin, David Mitchell, Blood	2015	29
Production and release of heat-labile toxin by wild-type human-derived enterotoxigenic<i>Escherichia coli</i> Melissa A. Lasaro, Juliana FalcÃ£o Rodrigues, Camila Mathias-Santos, FEMS Immunology & Medical Microbiology Microbial ToxinClinical SymptomsToxinologyVirulence FactorFoodborne Pathogens	2006	28

Page 1